PBM model is a ‘dead man walking.’ What comes next? Executives from Amazon, Walgreens, Blue Shield of California and PhRMA weighed in on how to fix the much-scrutinized pharmacy benefit ...

While the PBM provisions in the 1,547-page stopgap bill are now dead, they are far from buried. The bipartisan agreement highlighted a growing consensus that PBM business models are flawed, with ...

It edged out a few “transparent PBMs” — a sign, in Wojcik’s view, that CVS at least doesn’t want to be left out as more customers ditch the current PBM business model.

The PBM business model has done little to benefit patients and instead resulted in unprecedented profits obtained from federal, state and local governments, employer health plan sponsors and ...

A bipartisan group of lawmakers said Wednesday that they seek to lower drug costs by prohibiting joint ownership of pharmacy-benefit managers (PBM) and pharmacies. “PBMs have manipulated the ...

Pharmacy benefit manager WellDyne is partnering with ... this Waltz AI engine to WellDyne's commitment to transparency and next-generation models is not really a tweak to the PBM business model ...

Investment Thesis. CVS Health (NYSE:CVS) has plunged to $49 amid fears over PBM reform following an FTC lawsuit alleging abusive practices like rebate retention and price manipulation.With PBMs ...

Analyst Allen Lutz of Bank of America Securities reiterated a Sell rating on GoodRx Holdings (GDRX – Research Report), reducing the price target to $4.50. Allen Lutz has given his Sell rating ...

Executives from Amazon, Walgreens, Blue Shield of California and PhRMA weighed in on how to fix the much-scrutinized pharmacy benefit manager model during HLTH 2024.